Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis—a systematic review

Bente Braun(Universität Hamburg), Vivien Häußler(Universität Hamburg), Alice Mariottini(Azienda Ospedaliero-Universitaria Careggi), Christoph Heesen(Universität Hamburg), Johanna Richter(The University of Queensland), Dietlinde Janson(Universität Hamburg), Nicolaus Kröger(Universität Hamburg), Lena Kristina Pfeffer(Universität Hamburg), Felix Fischbach(Universität Hamburg)

European Journal of Neurology

August 5, 2024

10.1111/ene.16427

Cited by 6

Related Papers

Exercise in patients with multiple sclerosis

|The Lancet Neurology|2017|455

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

|Haematologica|2019|353

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

|Journal of Clinical Oncology|2017|248

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors

|Haematologica|2021|236

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

|Bone Marrow Transplantation|2014|192